Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9514
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNayler, W Gen
dc.date.accessioned2015-05-15T22:38:09Z
dc.date.available2015-05-15T22:38:09Z
dc.date.issued1992-05-16en
dc.identifier.citationJournal of Cardiovascular Pharmacology; 20 Suppl 5(): S14-7en
dc.identifier.govdoc1282608en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9514en
dc.description.abstractOxy and hydroxy radicals produced during postischemic reperfusion may contribute to the mechanisms responsible for the sustained contractile dysfunction and ultrastructural injury that occur under these conditions. At the molecular level, the consequent peroxidation of membrane-located lipids (including membranes that delineate the sarcoplasmic reticulum, the mitochondria, and the myocytes) probably contributes to the associated loss of Ca2+ homeostasis. Protection against oxy and hydroxy radical-induced injury can be approached in several ways. Oxy and hydroxy radical formation can be limited, or the radicals "trapped." Alternatively, agents that protect membranes against lipid peroxidation-induced injury can be used. To determine whether the calcium antagonist nisoldipine has such a protective effect, isolated hearts were exposed to 0.9 mM H2O2 for short periods of time, and the functional recovery on removal of the H2O2 was used to assess the protective effect of 5 x 10(-9) M nisoldipine. In addition, further evidence of protection was obtained by exposing hearts to an oxy radical-generating system in the presence and absence of 10(-8) M nisoldipine and using the inhibitory effect of nisoldipine on the oxy radical-induced externalization of the endothelin-1 ETA binding sites to quantify protection.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherBinding Sitesen
dc.subject.otherEndothelins.metabolismen
dc.subject.otherFree Radicals.metabolismen
dc.subject.otherHydrogen Peroxide.metabolism.toxicityen
dc.subject.otherHydroxides.metabolismen
dc.subject.otherHydroxyl Radicalen
dc.subject.otherIn Vitro Techniquesen
dc.subject.otherMyocardial Contraction.drug effectsen
dc.subject.otherMyocardial Reperfusion Injury.physiopathology.prevention & controlen
dc.subject.otherNisoldipine.pharmacologyen
dc.subject.otherRatsen
dc.subject.otherReactive Oxygen Species.metabolismen
dc.titleThe role of oxygen radicals during reperfusion.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Cardiovascular Pharmacologyen
dc.identifier.affiliationDepartment of Medicine, Austin Hospital, University of Melbourne, Heidelberg, Victoria, Australiaen
dc.description.pagesS14-7en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/1282608en
dc.type.austinJournal Articleen
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Dec 30, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.